{"id":377,"date":"2026-01-30T10:00:00","date_gmt":"2026-01-30T01:00:00","guid":{"rendered":"https:\/\/engitissuedesign.com\/?p=377"},"modified":"2026-09-28T15:33:54","modified_gmt":"2026-09-28T06:33:54","slug":"nyemissionen-hojer-aktiekapitalet-over-100-miljoner-yen-kapital-pa-111-351-300-yen","status":"publish","type":"post","link":"https:\/\/engitissuedesign.com\/sv\/nyemissionen-hojer-aktiekapitalet-over-100-miljoner-yen-kapital-pa-111-351-300-yen\/","title":{"rendered":"Nyemissionen h\u00f6jer aktiekapitalet \u00f6ver 100 miljoner yen (kapital p\u00e5 111\u202f351\u202f300 yen)"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Vi meddelar att EngiTissue Design Co., Ltd. den 30 januari 2026 genomf\u00f6rde en nyemission och h\u00f6jde aktiekapitalet till 111\u202f351\u202f300 yen. D\u00e4rmed har bolagets aktiekapital \u00f6verstigit 100 miljoner yen.<\/p>\n<ul class=\"wp-block-list\"><li>Ikrafttr\u00e4dandedatum: 30 januari 2026<\/li><li>Aktiekapital efter emissionen: 111\u202f351\u202f300 yen<\/li><li>Totalt antal utgivna aktier efter emissionen: 1\u202f214 aktier<\/li><\/ul>\n<p class=\"wp-block-paragraph\">Medlen som tagits in genom denna nyemission kommer att anv\u00e4ndas f\u00f6r att p\u00e5skynda v\u00e5r forskning och utveckling och f\u00f6r att expandera v\u00e5r verksamhet. Vi tackar f\u00f6r ert fortsatta st\u00f6d.<\/p>","protected":false},"excerpt":{"rendered":"<p>Vi meddelar att EngiTissue Design Co., Ltd. den 30 januari 2026 genomf\u00f6rde en nyemission och h\u00f6jde aktiekapitalet till 111\u202f351\u202f300 yen. D\u00e4rmed har bolagets aktiekapital \u00f6verstigit 100 miljoner yen. Ikrafttr\u00e4dandedatum: 30 januari 2026 Aktiekapital efter emissionen: 111\u202f351\u202f300 yen Totalt antal utgivna aktier efter emissionen: 1\u202f214 aktier Medlen som tagits in genom denna nyemission kommer att anv\u00e4ndas [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":597,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[103],"tags":[],"class_list":["post-377","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ir-och-kapital"],"_links":{"self":[{"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/posts\/377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/comments?post=377"}],"version-history":[{"count":1,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/posts\/377\/revisions"}],"predecessor-version":[{"id":378,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/posts\/377\/revisions\/378"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/media\/597"}],"wp:attachment":[{"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/media?parent=377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/categories?post=377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/tags?post=377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}